INVO Fertility (IVF) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
30 Dec, 2025Executive summary
Annual meeting scheduled for January 22, 2026, at 12:00 PM EST, to be held virtually.
Proxy materials are available online for shareholder review and voting.
Proxy is solicited by the Board of Directors, with Steve Shum appointed as proxy holder.
Voting matters and shareholder proposals
Ratification of WithumSmith + Brown, PC as independent auditors for fiscal year 2025.
Approval for issuance of common stock upon exercise of warrants from December 2025 private placement.
Amendment to articles of incorporation to increase authorized common stock to 250,000,000.
Amendment to stock incentive plan to increase shares available for issuance to 1,000,000.
Proposal to allow adjournment of the special meeting if necessary.
Board of directors and corporate governance
Board recommends voting FOR all five proposals presented at the meeting.
Proxy card must be signed exactly as names appear, with specific instructions for fiduciaries and joint owners.
Latest events from INVO Fertility
- Revenue and EBITDA improved sharply as acquisitions and technology drive clinic growth.IVF
Corporate presentation20 Mar 2026 - Clinic-focused fertility company targets $15M via warrant exercise, risking dilution.IVF
Registration Filing2 Feb 2026 - All proposals passed, enabling key steps in the strategic growth plan for the coming year.IVF
EGM 202622 Jan 2026 - Growth in fertility care is accelerating through clinic expansion, tech innovation, and acquisitions.IVF
2nd Annual Lytham Partners Healthcare Investor Summit15 Jan 2026 - Clinic revenue surged and losses narrowed as acquisitions and tech drive growth toward breakeven.IVF
Corporate presentation15 Jan 2026 - Shareholders to vote on auditor ratification, major share increase, warrant issuance, and plan amendment.IVF
Proxy Filing18 Dec 2025 - Registers 7.37M shares to fund fertility clinic expansion and operations, with dilution risks.IVF
Registration Filing17 Dec 2025 - Offering up to $100M in securities, the company faces high financial and operational risks.IVF
Registration Filing16 Dec 2025 - Proposals seek auditor ratification, major share authorization, and expanded equity incentives.IVF
Proxy Filing8 Dec 2025